Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Artemisinin antimalarials do not inhibit hemozoin formation

Richard K Haynes, Diego Monti, Donatella Taramelli

    Antimicrobial Agents and Chemotherapy
    |February 27, 2003
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Dual-Reporter Fluorescence-Luminescence Assay for Drug Screening in Promastigote and Intracellular Amastigote Stages of <i>Leishmania</i>.

    Molecules (Basel, Switzerland)·2026
    Same author

    Ruthenium Complexes of Atovaquone Acting on Multiple Stages of the <i>Plasmodium</i> Life Cycle.

    Journal of medicinal chemistry·2026
    Same author

    Exploring Novel Nitrofuryl-1,3,4-Thiadiazole-Based Derivatives: Design, Synthesis, and Evaluation of In Vitro Leishmanicidal and Trypanocidal Activity.

    Archiv der Pharmazie·2026
    Same author

    Diagnostic potential of circular RNAs in carotid atherosclerotic plaque vulnerability.

    Non-coding RNA research·2026
    Same author

    Examination of Coligands in Mefloquine-Metal Complexes Reveals the Structural Determinants of Activity against <i>Plasmodium falciparum</i> and <i>Schistosoma mansoni</i>.

    Journal of medicinal chemistry·2026
    Same author

    <i>Helicobacter pylori</i> Neutrophil Activating Protein (HP-NAP) Enhances the Anti-Leishmanial Activity of Canine Macrophages Against <i>Leishmania infantum</i>.

    Pathogens (Basel, Switzerland)·2026